Prof. Dr. Eric Tschirhart
![]() |
|
||||||||
Faculty or Centre | Faculty of Science, Technology and Medicine | ||||||||
Department | Department of Life Sciences and Medicine | ||||||||
Postal Address |
Université du Luxembourg Maison du Nombre 6, Avenue de la Fonte L-4364 Esch-sur-Alzette |
||||||||
Campus Office | MNO, E05 0525-070 | ||||||||
![]() |
|||||||||
Telephone | (+352) 46 66 44 6100 | ||||||||
Speaks | English, French | ||||||||
Research Stays in | Belgium, France, Luxembourg, Switzerland | ||||||||
Current positions
- Since August 1, 2002: Professor of Physiology at the University of Luxembourg
- January 2012 - January 2017: Vice-President, University of Luxembourg
- Since 2016: member of the Management committee of the Luxembourg University Foundation
- Since January 2017 - December 2018: Special Advisor to the President, Tech Transfer & Fundraising
- Since January 2019: Special Advisor to the Rector - UNIVERSEH | European University - University of the Greater Region
- Since October 2022: Expert for Evaluation of Higher Education Institutes, High Council for the Evaluation of Research and Higher Education (Hcéres, France)
Short bio
My research interests have been bronchial hyperreactivity delineation until the late 80s as a PhD student and endothelin receptor antagonist development in a US pharmaceutical research centre for cardiovascular and pulmonary targets until 1992.
As a group leader in the Centre de Recherche Public-Santé (Luxembourg), I then developed a research team to elucidate the control of superoxide anion secretion by calcium ion fluxes in human immune cells. Most developments implicated fluorescence measurement of biological and biochemical processes in live cellsin vitro, with a profound insight in the discovery of calcium-controlled transductional events leading to superoxide anions secretion. A complementary research activity linked to the investigation of oxidative stress consequences within the vascular wall was carried out.
Simultaneously, I taught physiology and pharmacology at the Centre Universitaire de Luxembourg (now University of Luxembourg) and at the University of Louvain (medical and pharmacy school) in Belgium.
After joining the University of Luxembourg late 2002, fluorescence-based studies became fully functional in autumn 2004. Aside, an interest was developed for the consequences of spaceflight on animal and human immunological system.
Since 2006, I have occupied various positions at the management of the University, being initially special advisor to the President for research management, then Director of Administration; after having managed Academic Affairs as Vice-president for nearly 5 years, I am in charge of Technology Transfer and Fundraising for the University, as Special Advisor to the President.
Check my:
- peer-reviewed publications via the Publications tab above
- LinkedIn profile
Last updated on: Tuesday, 07 February 2023
Degrees
- Qualification "Fonctions de Professeur des Universités", section n°65: cell biology and section n°66: physiology, by the "Conseil National des Universités" (Journal Officiel de la République Française, n°147 du 267 juin 2001, page 10184), 2002
- Habilitation à diriger des recherches, University of Nancy I, 1994
- PhD in pharmacology, University of Strasbourg I, France,Paracrine regulation of bronchial smooth muscle tone (summa cum laude), 1986-1988
- Master in Business Administration (DESS-CAAE), Institut d'Administration des Entreprises, Université de Nancy II, 1997
Research Interests
- Inflammation, oxidative stress and calcium fluxes
- Oxidative stress and matrix metalloproteinases
- Development of applications of biophysical techniques to study physiological processes in live
- Cells or tissues, drug development application
- Pharmacology and pharmaco-chemistry of anti-inflammatory drugs
Supervision of 10 PhDs at European level
Membership in Scientific Societies
- American Physiological Society
- British Pharmacological Society
- French society of Pharmacology
Linkedin: linkedin.com/in/erictschirhart
Last updated on: 12 Jul 2017
Member of Boards
- Former Member of the Board of the Centre de Recherche Public Gabriel Lippmann
- Former Member of the Board of Axoglia Therapeutics (representing the University and the Société Nationale de Crédit et d’Investissement)
- Member of the Management committee of the Luxembourg University Foundation
Evaluation Activities
- 2010: member of the International Evaluation Committee of the University of Rennes 1
- Since 2007, responsible and general coordinator for the evaluation process of the University of Luxembourg
- Recurrent reviewer for scientific journals (selection):
- Fund. Clin. Pharmacol.
- Eur. J. Pharmacol.
- Current Med. Chem.
- J. Med. Chem.
- Biochimica et Biophysica Acta
- Cell Calcium
- Thrombosis Research
- Bioorganic and Medicinal Chemistry
- Annals of Nutrition
- J. Pharmacol. Exp. Ther.
- Diabetologia
- External expert for research agencies (selection):
- INSERM (F)
- Agence Nationale de la Recherche (F)
- External expert for foreign universities
- Reviewer for research grants at University of Lille and INSERM
Last updated on: 07 Feb 2023
Here is a selection of links to publications about my activities as Vice-President and as Special Advisor to the President, at the University of Luxembourg released in domestic and international media
2016 |
||
Date |
Title |
Media |
25.05.2016 |
Radio 100,7 |
|
11.05.2016 |
Paperjam |
|
25.04.2016 |
Paperjam |
|
20.04.2016 |
Juste Avant de Zapper, 20 avril 2016 - L'université du Luxembourg a la cote (video) |
Mirabelle TV |
12.04.2016 |
Numen Europe et Labgroup accompagnent l’Université du Luxembourg dans sa transformation digitale |
Merkur |
11.04.2016 |
chronicle.lu |
|
16.03.2016 |
L'essentiel |
|
25.02.2016 |
Paperjam |
2015 |
||
Date |
Title |
Media |
03.11.2015 |
Ideas from Europe: Oswald Schröder est le candidat pour le Luxembourg |
Paperjam |
28.10.2015 |
les frontaliers |
|
04.10.2015 |
Le Quotidien |
|
02.10.2015 |
Paperjam |
|
29.09.2015 |
Radio 100,7 |
|
24.09.2015 |
Paperjam |
|
21.09.2015 |
Paperjam |
|
16.09.2015 |
Michel Wurth : « Arcelor Mittal avait une responsabilité historique à Belval » |
Le Quotidien |
08.09.2015 |
Belval – Design, le nouveau restaurant universitaire ouvre ses portes |
Le Quotidien |
08.09.2015 |
Le Quotidien |
|
03.07.2015 |
Paperjam |
|
19.06.2015 |
Promotion du réseau -actions positives- par Lydia Mutsch lors des Greater Region Business Days |
gouvernement.lu |
16.05.2015 |
L’Université du Luxembourg dématérialise ses dossiers d’inscription |
Solutions numériques |
30.03.2015 |
Luxemburger Wort |
|
23.03.2015 |
L'essentiel |
|
30.01.2015 |
L'essentiel |
|
21.01.2015 |
Au Luxembourg, un doctorat financé à 100% par les industriels |
letudiant.fr |
15.01.2015 |
L'essentiel |
2014 |
||
Date |
Title |
Media |
20.12.2014 |
Inauguration des premières résidences universitaires à Belval |
Luxemburger Wort |
19.12.2014 |
Luxemburger Wort |
|
11.09.2016 |
5vier.de |
|
10.09.2014 |
Luxemburger Wort |
|
15.04.2014 |
Peoplesphere.lu |
|
04.04.2014 |
Paperjam |
|
14.03.2014 |
Paperjam |
|
10.03.2014 |
SIC Europa |
|
21.02.2014 |
Enseignement universitaire ouvert : Révolution ou poudre aux yeux ? |
woxx |
29.01.2014 |
Aufgestockt: Neue Studiengänge für Ingenieure sollen mehr Studenten anlocken |
Journal.lu |
2013 |
||
Date |
Title |
Media |
12.09.2013 |
Paperjam |
|
17.06.2013 |
Numen Europe dématérialise plus de 6.500 dossiers étudiants de l’Université du Luxembourg |
Paperjam |
18.06.2013 |
L’Université du Luxembourg dématérialise plus de 6500 dossiers étudiants |
ITnation.lu |
06-07.2013 |
soluxions Business Technologies |
|
22.05.2013 |
A l'uni.lu, le luxembourgeois n'est pas utilisé pour les cours |
Luxemburger Wort |
2012 |
||
Date |
Title |
Media |
05.10.2012 |
Les étudiants attendent toujours une reconnaissance officielle : Jeunes travailleurs intellectuels |
Luxemburger Wort |
Last updated on: 12 Jul 2017

2018

; ; ; ; ; ; ;
in Frontiers in immunology (2018), 9
2015

; ; ; ; ;
in Journal of Immunology Research (2015), 2015
2014

; ; ; ; ; ; ;
in Journal of Leukocyte Biology (2014), 97
2013

; ;
in Antioxidants & Redox Signaling (2013), 18(6), 661-676

; ; ; ; ; ; ; ; ;
in Biology of the Cell (2013)

; ; ; ; ; ; ;
in FASEB Journal (2013), 27(1), 333-341
2012

; ;
in Khatami, Mahin (Ed.) Inflammation, Chronic Diseases and Cancer - Cell and Molecular Biology, Immunology and Clinical Bases (2012)

; ; ; ; ; ; ;
in Psychoneuroendocrinology (2012), 37(1), 137-147
2011

; ; ; ;
in Journal of Leukocyte Biology (2011), 89(4), 587-596

; ; ; ;
in Journal of Immunology (2011), 186(4), 2182-2191
2010

; ; ; ; ; ; ; ; ; ;
in Drug Development Research (2010), 71

; ; ; ; ;
in Biochimica et Biophysica Acta-Molecular Cell Research (2010), 1803(7), 840-847
2009

; ; ; ;
in FASEB Journal (2009), 23(5), 1607-1615

; ; ;
in Biochemical Pharmacology (2009), 78(5), 504-513

; ;
in Journal of Leukocyte Biology (2009), 85(4), 638-647

; ; ; ; ; ;
in Journal of Leukocyte Biology (2009), 86(5), 1027-1038

in Landry, Yves; Gies, Jean-Pierre (Eds.) Pharmacologie. Des cibles vers l’indication thérapeutique (2009)
2008

; ; ; ;
in Journal of Cell and Animal Biology (2008), 2(9), 160-165

;
in Journal of Leukocyte Biology (2008), 84(5), 1223-1237

; ; ; ; ;
in Calcium Binding Proteins (2008), 3(1), 25-30
2006

; ; ;
in Biochimica et Biophysica Acta (2006), 1763(1), 129-36

; ; ; ;
in British Journal of Pharmacology (2006), 148(4), 544-52
2005

; ;
in Cell Calcium (2005), 37(6), 531-40

; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
in Journal of Immunotoxicology (2005), 2(2), 61-83

; ; ; ;
in Fundamental and Clinical Pharmacology (2005), 19(6), 661-7
2001

; ;
in Biochimica et Biophysica Acta (2001), 1538(2-3), 252-9

; ; ; ;
in Biochemical Pharmacology (2001), 61(9), 1169-75

; ; ; ; ;
in Biochemical Pharmacology (2001), 61(4), 485-91

; ; ;
in Cell Calcium (2001), 29(6), 409-15

;
in Inflammation Research (2001), 50(7), 357-61
2000

; ; ; ; ;
in British Journal of Pharmacology (2000), 131(7), 1337-44
1999

; ;
in European Journal of Pharmacology (1999), 361(2-3), 293-8

; ; ; ; ; ; ; ;
in Biochimica et Biophysica Acta (1999), 1440(2-3), 266-74

; ;
in Cell Calcium (1999), 25(5), 381-9

;
in Thérapie (1999), 54(1), 103-9
1997

; ; ; ;
in Journal of Immunological Methods (1997), 205(1), 1-9
1996

; ;
in Fundamental and Clinical Pharmacology (1996), 10(1), 28-32
1995

; ; ; ;
in Biochimica et Biophysica Acta (1995), 1244(1), 79-84
1993

; ; ; ;
in Pulmonary Pharmacology (1993), 6(1), 69-76

;
in Fundamental and Clinical Pharmacology (1993), 7(6), 261-73
1992

; ;
in Immunopharmacology (1992), 22(2), 115-25
1991

; ;
in Agents and Actions. Supplements (1991), 31

; ; ; ;
in Journal of Pharmacology and Experimental Therapeutics (1991), 258(1), 381-7

; ;
in Agents and Actions. Supplements (1991), 31
1990

; ; ;
in Naunyn-Schmiedeberg's Archives of Pharmacology (1990), 342(2), 177-81
1989

; ;
in International Archives of Allergy and Applied Immunology (1989), 88(4), 439-46

; ; ; ; ;
in Journal of Pharmacology and Experimental Therapeutics (1989), 250(1), 329-35

; ; ; ; ; ;
in Naunyn-Schmiedeberg's Archives of Pharmacology (1989), 340(1), 107-10
1987

; ; ;
in Journal of Pharmacology and Experimental Therapeutics (1987), 243(1), 310-6

;
in European Journal of Pharmacology (1987), 132(1), 103-4